<?xml version="1.0" encoding="UTF-8"?>
<p>Recently, it has been suggested that COVID-19 induces hypoxic pulmonary vasoconstriction similar to high altitude pulmonary edema (HAPE), therefore medications found to be effective in HAPE, including the use of acetazolamide, nifedipine and phosphodiesterase inhibitors to decrease pulmonary vasoconstriction has been suggested [
 <xref rid="B138-jcm-09-01917" ref-type="bibr">138</xref>]. It must be underlined that as new data regarding COVID-19 is emerging this approach remains controversial [
 <xref rid="B139-jcm-09-01917" ref-type="bibr">139</xref>].
</p>
